Lyophilization Technologies

Lyophilization Technology, Inc. (LTI) is a specialized Contract Development and Manufacturing Organization (CDMO) focused exclusively on the science and technology of freeze-drying for the healthcare industry. Founded in 1992 and headquartered in Ivyland, Pennsylvania, the company provides a comprehensive range of services including formulation development, cycle design, thermal analysis, and clinical trial material manufacturing. LTI supports a diverse array of product types such as biologics, vaccines, small molecules, and highly potent compounds, from pre-clinical through Phase III clinical supplies. The firm operates state-of-the-art facilities equipped with ISO 5 cleanrooms and utilizes advanced technologies like nucleation on-demand to ensure robust and scalable processes. With over 30 years of experience and a track record of collaborating with more than 500 organizations globally, LTI is a recognized leader in stabilizing sensitive therapeutic and diagnostic products.